Rice to the rescue: new study tests Low-GI, High-Protein rice for diabetes prevention
NCT ID NCT07663123
First seen Jun 24, 2026
Summary
The HARVEST study is testing whether eating a special low-glycemic, high-protein rice instead of regular white rice can improve blood sugar control in people with prediabetes or type 2 diabetes. Over 16 weeks, 225 adults in Singapore will replace their usual rice with one of three types: regular white rice, low-GI rice, or low-GI high-protein rice. The goal is to see if this simple swap can lower HbA1c levels and help prevent diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES / TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
functional rice varieties (low glycemic index and high protein rice)
What this could lead to
If successful, this could provide a simple, culturally acceptable way to help manage blood sugar and prevent progression to type 2 diabetes without major diet changes.
What could go wrong
This is a relatively small, early-stage trial (225 participants) and results may not apply to other populations. The rice is a dietary supplement, not a drug, so effects may be modest.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.